Showing results (91-100 of 182) with videos related to
Sort By:
Pageof 19
Plos One|June 28, 2019
Utility of a ready-to-use PCR system for neuroendocrine tumor diagnosisMark Kidd, Ignat A Drozdov, Somer Matar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2010
68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumorsValentina Ambrosini, Davide Campana, Lisa Bodei, et al.Medical Physics|September 1, 2023
The risk index as a basis for risk/benefit analyses and protocol optimization in diagnostic nuclear imagingJuan C Ocampo Ramos, Lukas M Carter, Justin L Brown, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 2, 2023
MIRD Pamphlet No. 28, Part 2: Comparative Evaluation of MIRDcalc Dosimetry Software Across a Compendium of Diagnostic RadiopharmaceuticalsLukas M Carter, Juan C Ocampo Ramos, Edmond A Olguin, et al.Annals of Surgical Oncology|September 11, 2016
Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver MetastasesEmilio Bertani, Nicola Fazio, Davide Radice, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 24, 2021
Somatostatin Receptor Imaging and Theranostics: Current Practice and Future ProspectsSonya Park, Ashwin Singh Parihar, Lisa Bodei, et al.Surgery|March 4, 2014
Resection of the primary pancreatic neuroendocrine tumor in patients with unresectable liver metastases: possible indications for a multimodal approachEmilio Bertani, Nicola Fazio, Edoardo Botteri, et al.Cancer Biotherapy & Radiopharmaceuticals|July 10, 2014
Planning combined treatments of external beam radiation therapy and molecular radiotherapyMarta Cremonesi, Mahila Ferrari, Francesca Botta, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 5, 2006
Semiautomated analysis of small-animal PET dataAdam L Kesner, Magnus Dahlbom, Sung-Cheng Huang, et al.Cancer Biotherapy & Radiopharmaceuticals|December 23, 2009
Lymphocytic toxicity in patients after peptide-receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOCMaribel L Sierra, Alberto Agazzi, Lisa Bodei, et al.Pageof 19